Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.57 |
| ▸ | CA2 | P00918 | 5/20 | 0.57 |
| ▸ | CA7 | P43166 | 4/20 | 0.57 |
| ▸ | CA9 | Q16790 | 4/20 | 0.39 |
| ▸ | CA4 | P22748 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19741292 | 0.98 | CA1 (0.55) | CA1CA2CA7CA9CA4 | |
| SCHEMBL19741291 | 0.91 | CA1 (0.52) | CA1CA2CA7CA9CA4 | |
| SCHEMBL19741473 | 0.89 | CA1 (0.50) | CA1CA2CA7CA9CA4 | |
| SCHEMBL6424785 | 0.85 | CA1 (0.63) | CA1CA2CA7CA9CA4 | |
| SCHEMBL8926368 | 0.85 | CA1 (0.46) | CA1CA2CA7CA9CA4 | |
| SCHEMBL11653148 | 0.84 | CA1 (0.45) | CA1CA2CA7 | |
| SCHEMBL15339872 | 0.81 | CA1 (0.46) | CA1CA2CA7CA9CA4 | |
| SCHEMBL497334 | 0.80 | CA1 (0.74) | CA1CA2CA7CA9CA4 | |
| SCHEMBL6420386 | 0.80 | CA1 (0.57) | CA1CA2CA7CA9CA4 | |
| SCHEMBL27530666 | 0.80 | CA1 (0.57) | CA1CA2CA7CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10597360-B2 | Prepolymers exhibiting rapid development of physical properties | PRC-DESOTO INTERNATIONAL, INC. (US) | 2020-03-24 | — | — | US | claimed |
| US-20180155280-A1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PRC-DESOTO INTERNATIONAL, INC. | 2018-06-07 | — | — | US | claimed |
| EP-3475338-B9 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PRC DESOTO INT INC (US) | 2022-10-19 | — | — | EP | disclosed |
| EP-3475338-B1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PRC DESOTO INT INC (US) | 2022-08-03 | — | — | EP | disclosed |
| CN-109415511-B | Prepolymers exhibiting fast forming physical properties | PRC-迪索托国际公司 | 2021-07-30 | — | — | CN | disclosed |
| US-10597360-B2 | Prepolymers exhibiting rapid development of physical properties | PRC-DESOTO INTERNATIONAL, INC. (US) | 2020-03-24 | — | — | US | disclosed |
| US-20180155280-A1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PRC-DESOTO INTERNATIONAL, INC. | 2018-06-07 | — | — | US | disclosed |
| US-9920006-B2 | Prepolymers exhibiting rapid development of physical properties | PRC-DESOTO INTERNATIONAL, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20170369432-A1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PRC-DESOTO INTERNATIONAL, INC. | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369432-A1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PLOD1, TTPA, XRCC6 | CA1 4630/4885CA2 4714/4885CA7 4435/4885 |
| US-10597360-B2 | Prepolymers exhibiting rapid development of physical properties | PLOD1, TTPA, XRCC6 | CA1 4630/4885CA2 4714/4885CA7 4435/4885 |
| US-20180155280-A1 | PREPOLYMERS EXHIBITING RAPID DEVELOPMENT OF PHYSICAL PROPERTIES | PLOD1, TTPA, XRCC6 | CA1 4630/4885CA2 4714/4885CA7 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.